This is great news for Solbec, the renal cell carcinoma patient fron the Phase 1 trial with the 15 month ongoing response I guess was a compelling reason to grant orphan drug. It means total protection from competition in the US for coramsine on renal cell cancer.
- Forums
- ASX - By Stock
- SBP
- fda grants orphan drug to coramsine
SBP
solbec pharmaceuticals limited
fda grants orphan drug to coramsine, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)